Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Non Therapeutic Biomolecules Market Report 2024

Non-Therapeutic Biomolecules Global Market Report 2025 – By Trad Pharma( Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies), By End User( Research, Pharma, In vitro diagnostics(IVD)) – Market Size, Trends, And Global Forecast 2025-2034

Non-Therapeutic Biomolecules Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Non-Therapeutic Biomolecules Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Non-Therapeutic Biomolecules Market Definition

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.

The main types of trad pharma of non-therapeutic biomolecules are enzymes, recombinant proteins, plasmids, peptides, oligonucleotides, and monoclonal antibodies. Enzymes are globular conjugated proteins that catalyze biological reactions by reducing the activation energy that increases the rate of the reaction. These are used by various end users such as research, pharma and In vitro diagnostics(IVD).

Non-Therapeutic Biomolecules Market Segmentation

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Non-Therapeutic Biomolecules Market Size and growth rate 2025 to 2029: Graph

Non-Therapeutic Biomolecules Market Size 2025 And Growth Rate

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $30.76 billion in 2024 to $34.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support.

Non-Therapeutic Biomolecules Market Growth Forecast

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $52.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization.

Book your 30 minutes free consultation with our research experts

Contact Us

Non-Therapeutic Biomolecules Market Driver: The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing

The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created, or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, in July 2024, according to the National Health Service (NHS), a UK-based hospital and health care provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to the previous year. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules market.

Non-Therapeutic Biomolecules Market Driver: The Role Of Increased Healthcare Expenditure In Driving Growth Of The Non-Therapeutic Biomolecules Market

The increased healthcare expenditure is expected to propel the growth of the non-therapeutic biomolecules market going forward. Increased healthcare expenditure often leads to greater funding for medical research and development. Non-therapeutic biomolecules are often used in diagnostic tools and tests. Higher healthcare spending may indicate a greater emphasis on disease prevention, early detection, and personalized medicine. This increased focus on diagnostics can contribute to the growth of the non-therapeutic biomolecules market. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, in 2023, healthcare expenditure in the UK was approximately £292 billion, reflecting a nominal increase of 5.6%. Additionally, long-term health and social care expenditure rose by 2.8% in real terms in 2022. Therefore, the increased healthcare expenditure is driving the growth of the non-therapeutic biomolecules market during forecast period.

Global Non-Therapeutic Biomolecules Market Major Players

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, EppendoRF AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Global Non-Therapeutic Biomolecules Market Trend: BASF And Caregen's Partnership Unleashes Innovative Peptovitae Series With Liposome-Encapsulation Technology

Product innovations are a key trend gaining popularity in the non-therapeutic biomolecules market. Major companies operating in the market are focused on research and development for product innovations to sustain their position in the market. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company partnered with Caregen, a Korean-based company operating in biomimetic peptide research and development and introduced the Peptovitae series manufactured using liposome-encapsulation technology to expand its dermo-cosmetics portfolio to address a broad range of skin concerns with innovative and differentiated solutions. Liposomal encapsulation is a technique that uses fats to deliver essential vitamins or medications to specific body sections in tiny bubbles without affecting other body parts. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides such as signs of aging, enhancing the brightness of the skin, soothing skin prone to dryness and itching, and moisturizing skin.

Global Non-Therapeutic Biomolecules Market Trend: Development Of New Cell Separation Technology To Increase Throughput And Optimize Processes

Major companies in the non-therapeutic biomolecules market are focusing on developing new cell separation technology to increase throughput and optimize processes, thus, to gain a competitive advantage in the market. This innovative research-only kit is created to provide scientists with a crucial solution to biological and lab workflow difficulties. For instance, in September 2022, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit. The device combines the distinct features of microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube, which has the potential to revolutionize large-volume cell separation procedures. The Microbubble Leukopak Human T Cell Isolation Kit employs microbubble technology which allows scientists to process up to twice the number of leukopaks in one-third the time of typical procedures, increasing productivity and optimizing operations.

Non-Therapeutic Biomolecules Market Merger And Acquisition: Abbvie Acquires DJS Antibodies To Enhance Monoclonal Antibody Development

In October 2022, AbbVie Inc., a US-based healthcare company, acquired DJS Antibodies for $255 million. This acquisition aims to leverage DJS's innovative antibody technology and expertise in developing monoclonal antibodies, which can accelerate AbbVie's research and development efforts in targeted treatments. DJS Antibodies is a UK-based biopharmaceutical company that specializes in creating novel monoclonal antibodies for therapeutic applications.

Regional Outlook For The Global Non-Therapeutic Biomolecules Market

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-therapeutic biomolecules market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Therapeutic Biomolecules Market?

The non-therapeutic biomolecule market consists of sales of monosaccharides, disaccharides, polysaccharides, heteropolysaccharides, structural proteins, hormones, respiratory pigments, storage proteins, toxins, deoxyribonucleic acids (DNA), ribonucleic acids (RNA), fatty acids, phospholipids, steroids, eicosanoids, and glycolipids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Non-Therapeutic Biomolecules Industry?

The non-therapeutic biomolecules market research report is one of a series of new reports from The Business Research Company that provides non-therapeutic biomolecules market statistics, including the non-therapeutic biomolecules industry’s global market size, regional shares, competitors with a non-therapeutic biomolecules market share, detailed non-therapeutic biomolecules market segments, market trends, and opportunities, and any further data you may need to thrive in the non-therapeutic biomolecules industry. This non-therapeutic biomolecules market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Non-Therapeutic Biomolecules Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $34.23 billion
Revenue Forecast In 2034 $52.15 billion
Growth Rate CAGR of 11.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD) Subsegments: 1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides 6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Non-Therapeutic Biomolecules Market Characteristics

    3. Non-Therapeutic Biomolecules Market Trends And Strategies

    4. Non-Therapeutic Biomolecules Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Non-Therapeutic Biomolecules Growth Analysis And Strategic Analysis Framework

    5.1. Global Non-Therapeutic Biomolecules PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Non-Therapeutic Biomolecules Market Growth Rate Analysis

    5.4. Global Non-Therapeutic Biomolecules Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Non-Therapeutic Biomolecules Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Non-Therapeutic Biomolecules Total Addressable Market (TAM)

    6. Non-Therapeutic Biomolecules Market Segmentation

    6.1. Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Enzymes

    Recombinant Proteins

    Plasmids

    Peptides

    Oligonucleotides

    Monoclonal Antibodies

    6.2. Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research

    Pharma

    In vitro diagnostics(IVD)

    6.3. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Industrial Enzymes

    Diagnostic Enzymes

    6.4. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antigens

    Cytokines

    Growth Factors

    6.5. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research Plasmids

    Expression Plasmids

    6.6. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antimicrobial Peptides

    Signaling Peptides

    6.7. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Antisense Oligonucleotides

    RNAi Oligonucleotides

    6.8. Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Research Antibodies

    Diagnostic Antibodies

    7. Non-Therapeutic Biomolecules Market Regional And Country Analysis

    7.1. Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Non-Therapeutic Biomolecules Market

    8.1. Asia-Pacific Non-Therapeutic Biomolecules Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Non-Therapeutic Biomolecules Market

    9.1. China Non-Therapeutic Biomolecules Market Overview

    9.2. China Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Non-Therapeutic Biomolecules Market

    10.1. India Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Non-Therapeutic Biomolecules Market

    11.1. Japan Non-Therapeutic Biomolecules Market Overview

    11.2. Japan Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Non-Therapeutic Biomolecules Market

    12.1. Australia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Non-Therapeutic Biomolecules Market

    13.1. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Non-Therapeutic Biomolecules Market

    14.1. South Korea Non-Therapeutic Biomolecules Market Overview

    14.2. South Korea Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Non-Therapeutic Biomolecules Market

    15.1. Western Europe Non-Therapeutic Biomolecules Market Overview

    15.2. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Non-Therapeutic Biomolecules Market

    16.1. UK Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Non-Therapeutic Biomolecules Market

    17.1. Germany Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Non-Therapeutic Biomolecules Market

    18.1. France Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Non-Therapeutic Biomolecules Market

    19.1. Italy Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Non-Therapeutic Biomolecules Market

    20.1. Spain Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Non-Therapeutic Biomolecules Market

    21.1. Eastern Europe Non-Therapeutic Biomolecules Market Overview

    21.2. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Non-Therapeutic Biomolecules Market

    22.1. Russia Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Non-Therapeutic Biomolecules Market

    23.1. North America Non-Therapeutic Biomolecules Market Overview

    23.2. North America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Non-Therapeutic Biomolecules Market

    24.1. USA Non-Therapeutic Biomolecules Market Overview

    24.2. USA Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Non-Therapeutic Biomolecules Market

    25.1. Canada Non-Therapeutic Biomolecules Market Overview

    25.2. Canada Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Non-Therapeutic Biomolecules Market

    26.1. South America Non-Therapeutic Biomolecules Market Overview

    26.2. South America Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Non-Therapeutic Biomolecules Market

    27.1. Brazil Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Non-Therapeutic Biomolecules Market

    28.1. Middle East Non-Therapeutic Biomolecules Market Overview

    28.2. Middle East Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Non-Therapeutic Biomolecules Market

    29.1. Africa Non-Therapeutic Biomolecules Market Overview

    29.2. Africa Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Non-Therapeutic Biomolecules Market Competitive Landscape And Company Profiles

    30.1. Non-Therapeutic Biomolecules Market Competitive Landscape

    30.2. Non-Therapeutic Biomolecules Market Company Profiles

    30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Non-Therapeutic Biomolecules Market Other Major And Innovative Companies

    31.1. Thermo Fisher Scientific Inc.

    31.2. Agilent Technologies Inc.

    31.3. Charles River Laboratories International Inc.

    31.4. GE Healthcare Life Sciences

    31.5. Fujifilm Diosynth Biotechnologies

    31.6. Evonik Industries AG

    31.7. Seikagaku Corporation

    31.8. Takeda Pharmaceutical Company Limited

    31.9. MilliporeSigma

    31.10. Covance Inc.

    31.11. Sartorius AG

    31.12. Sanofi S.A.

    31.13. CordenPharma International

    31.14. Bayer AG

    31.15. WuXi AppTec

    32. Global Non-Therapeutic Biomolecules Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market

    34. Recent Developments In The Non-Therapeutic Biomolecules Market

    35. Non-Therapeutic Biomolecules Market High Potential Countries, Segments and Strategies

    35.1 Non-Therapeutic Biomolecules Market In 2029 - Countries Offering Most New Opportunities

    35.2 Non-Therapeutic Biomolecules Market In 2029 - Segments Offering Most New Opportunities

    35.3 Non-Therapeutic Biomolecules Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: UK, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: UK, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Germany, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Germany, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: France, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: France, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Italy, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Italy, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Spain, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Spain, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Russia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Russia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: North America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: North America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: USA, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: USA, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Canada, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Canada, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: South America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: South America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Africa, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Africa, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Amgen Inc. Financial Performance
  • Table 58: Genentech Inc. Financial Performance
  • Table 59: Merck KGaA Financial Performance
  • Table 60: Lonza Group AG Financial Performance
  • Table 61: Bio-Rad Laboratories Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Plasmids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Non-Therapeutic Biomolecules Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Non-Therapeutic Biomolecules Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Non-Therapeutic Biomolecules Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Indonesia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: South Korea, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Western Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: UK, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: UK, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Germany, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Germany, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: France, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: France, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Italy, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Italy, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Spain, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Spain, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Eastern Europe, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Russia, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Russia, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: North America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: North America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: USA, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: USA, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Canada, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Canada, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: South America, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: South America, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Brazil, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Middle East, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Africa, Non-Therapeutic Biomolecules Market, Segmentation By Trad Pharma, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Africa, Non-Therapeutic Biomolecules Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Amgen Inc. Financial Performance
  • Figure 58: Genentech Inc. Financial Performance
  • Figure 59: Merck KGaA Financial Performance
  • Figure 60: Lonza Group AG Financial Performance
  • Figure 61: Bio-Rad Laboratories Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the generic pharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Scientific Research And Development Services Global Market Report 2025 – By Type (Social Sciences And Humanities Services, Physical, Engineering, And Life Sciences, Nanotechnology Services, Biotechnology Services), By Mode (Online, Offline), By End User Size (Large Enterprise, Small and Medium Enterprise) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Imaging Devices And Equipment Global Market Report 2025 – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications), By End-User (Hospitals, Imaging Centers, Academic & Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acne Drugs Global Market Report 2025 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hospitals & Clinics, Pharmacies & Drug Stores, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Small Animal Imaging (In-Vivo) Global Market Report 2025 – By Component (Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components), By Application (Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics), By End User (Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biologics Market 2022 - By Type (Therapeutic Proteins, Monoclonal Antibodies ((MAbS), Vaccines), By Route Of Administration (Oral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, Over-The-Counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the non-therapeutic biomolecules market?

Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning. For further insights on the non-therapeutic biomolecules market, request a sample here

How will the non-therapeutic biomolecules market drivers and restraints affect the non-therapeutic biomolecules market dynamics? What forces will shape the non-therapeutic biomolecules industry going forward?

The non-therapeutic biomolecules market major growth driver - Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.. For further insights on the non-therapeutic biomolecules market, request a sample here

What is the forecast market size or the forecast market value of the non-therapeutic biomolecules market?

The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $30.76 billion in 2024 to $34.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support. The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $52.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization. For further insights on the non-therapeutic biomolecules market, request a sample here

How is the non-therapeutic biomolecules market segmented?

The non-therapeutic biomolecules market is segmented
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD) Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic AntibodiesFor further insights on the non-therapeutic biomolecules market, request a sample here

Which region has the largest share of the non-therapeutic biomolecules market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the non-therapeutic biomolecules market, request a sample here.

Who are the major players in the non-therapeutic biomolecules market?

Major companies in the non-therapeutic biomolecules market are focusing on developing new cell separation technology to increase throughput and optimize processes, thus, to gain a competitive advantage in the market. This innovative research-only kit is created to provide scientists with a crucial solution to biological and lab workflow difficulties. For instance, in September 2022, Akadeum Life Sciences, a US-based biotechnology company, launched the Microbubble Leukopak Human T Cell Isolation Kit. The device combines the distinct features of microbubbles with a Buoyancy Activated Cell Sorting (BACSTM) Separation Tube, which has the potential to revolutionize large-volume cell separation procedures. The Microbubble Leukopak Human T Cell Isolation Kit employs microbubble technology which allows scientists to process up to twice the number of leukopaks in one-third the time of typical procedures, increasing productivity and optimizing operations. For further insights on the non-therapeutic biomolecules market, request a sample here.

What are the key trends in the non-therapeutic biomolecules market?

Major trend in the non-therapeutic biomolecules market - BASF And Caregen's Partnership Unleashes Innovative Peptovitae Series With Liposome-Encapsulation Technology. For further insights on the non-therapeutic biomolecules market, request a sample here.

What are the major opportunities in the non-therapeutic biomolecules market? What are the strategies for the non-therapeutic biomolecules market?

For detailed insights on the major opportunities and strategies in the non-therapeutic biomolecules market, request a sample here.

How does the non-therapeutic biomolecules market relate to the overall economy and other similar markets?

For detailed insights on non-therapeutic biomolecules market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the non-therapeutic biomolecules industry?

For detailed insights on the mergers and acquisitions in the non-therapeutic biomolecules industry, request a sample here.

What are the key dynamics influencing the non-therapeutic biomolecules market growth? SWOT analysis of the non-therapeutic biomolecules market.

For detailed insights on the key dynamics influencing the non-therapeutic biomolecules market growth and SWOT analysis of the non-therapeutic biomolecules industry, request a sample here.